MEROPENEM (MEROPENEM TRIHYDRATE) — all Canadian products
19 DINs
14 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is MEROPENEM (MEROPENEM TRIHYDRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02493330 | MEROPENEM FOR INJECTION | STERIMAX INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed | |
| 02378795 | MEROPENEM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed | |
| 02378787 | MEROPENEM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed | |
| 02536382 | MEROPENEM FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Approved | |
| 02462885 | MEROPENEM FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed | |
| 02462893 | MEROPENEM FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed | |
| 02493349 | MEROPENEM FOR INJECTION | STERIMAX INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed | |
| 02536374 | MEROPENEM FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed | |
| 02528827 | MEROPENEM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed | |
| 02528819 | MEROPENEM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed | |
| 02436493 | MEROPENEM FOR INJECTION USP | STERIMAX INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Approved | |
| 02421518 | TARO-MEROPENEM | SUN PHARMA CANADA INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed | |
| 02421526 | TARO-MEROPENEM | SUN PHARMA CANADA INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed | |
| 02554151 | VABOMERE | XEDITON PHARMACEUTICALS INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G; VABORBACTAM 1 G | Marketed | |
| 02430509 | MEROPENEM FOR INJECTION SDZ | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Cancelled Pre Market | |
| 02430495 | MEROPENEM FOR INJECTION SDZ | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Cancelled Pre Market | |
| 02436507 | MEROPENEM FOR INJECTION USP | STERIMAX INC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Dormant | |
| 02413787 | MEROPENEM FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Cancelled Pre Market | |
| 02413779 | MEROPENEM FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intravenous | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Cancelled Post Market |
Browse other molecules: